Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 9/20 | 0.42 |
| ▸ | DRD2 | P14416 | 6/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2735429 | 0.91 | DRD3 (0.42) | DRD3DRD2NPC1RAB9ALTA4H | |
| SCHEMBL216183 | 0.91 | DRD3 (0.42) | DRD3DRD2NPC1RAB9ALTA4H | |
| Hydrochloric Acid SCHEMBL215263 | 0.91 | DRD3 (0.41) | DRD3DRD2NPC1RAB9ALTA4H | |
| SCHEMBL214368 | 0.91 | DRD3 (0.41) | DRD3DRD2MAPT | |
| SCHEMBL2735447 | 0.90 | PTGDR (0.45) | DRD3DRD2NPC1RAB9AMAPT | |
| SCHEMBL2735375 | 0.90 | PTGDR (0.45) | DRD3DRD2NPC1RAB9AMAPT | |
| SCHEMBL215917 | 0.90 | NPC1 (0.41) | DRD3DRD2NPC1RAB9ALTA4H | |
| SCHEMBL214053 | 0.89 | DRD3 (0.38) | DRD3DRD2NPC1RAB9ALTA4H | |
| SCHEMBL2735368 | 0.87 | LTA4H (0.47) | NPC1RAB9ALTA4HKDM4EALDH1A1 | |
| SCHEMBL13320334 | 0.83 | MEN1 (0.41) | DRD3DRD2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2061768-A2 | IMIDAZOLE-4,5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS | Exelixis, Inc. (US) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008042282-A2 | IMIDAZOLE-4, 5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS | EXELIXIS, INC. (US) | 2008-04-10 | — | — | WO | disclosed |